January 22, 2026
1 min read

Abbott drops as Nutrition unit drives Q4 revenue miss

Abbott Laboratories (ABT) stock falls as underperformance in the company’s Nutrition segment leads it to record lower than expected Q4 sales. Read more here.

Leave a Reply

Your email address will not be published.

Previous Story

Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings.

Next Story

Global pharma manufacturing output surged in ’25 in ‘front-loading’ response to US tariff threats: report

Previous Story

Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings.

Next Story

Global pharma manufacturing output surged in ’25 in ‘front-loading’ response to US tariff threats: report

Latest from Blog

NEWS CENTER Maine

Through in-depth storytelling, through direct contact on digital on social platforms, through long-standing community service programs like Coats & Toys for Kids, Project Heat and Buddy to Buddy, NEWS CENTER Maine is
Go toTop